A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF TOPICAL CLINDAMYCIN 1% GEL VERSUS TOPICAL DAPSONE 5% GEL IN ACNE VULGARIS OVER FACE: A PROSPECTIVE RANDOMIZED DOUBLE BLIND STUDY. - NI

Dr Jyoti Gadhvi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年11月13日

试验速览

暂无简介。

•Patients having ISGA scoring of 1 or more at baseline.
•Patients who are willing to take part in the study with signed and written informed consent.
•Patients could be of both male and female.
•All patients who are 15-45 years of age
•Patient must be medically stable.
•Patient must have active mobile number.

•Pregnant, breast feeding, child bearing age using contraception.
•Patient with nodulocystic lesions (ISGA Grade 4 and ISGA Grade 5) at the baseline.
•Patient with a K/C/O any Autoimmune conditions like SLE, Thyroid disorder, Vitiligo, etc.
•Patient receiving systemic treatment relevant to Facial Acne Vulgaris within 3 months of enrollment.
•Patient receiving Topical treatment relevant to Facial Acne within 1 months
•Patient who are on medications like topical facial antibiotics, topical acne medicines, topical corticosteroids within 2 weeks.
•Patients who have undergone any facial procedures within 1 months.
•Patients using any systemic retinoids or received treatment with estrogens or anti-androgenic agents within 2 months.

发起方

Dr Jyoti Gadhvi